Phase 3 Open-Label Randomized Study of Amonafide L-Malate in Combination with Cytarabine Compared to Daunorubicin in Combination with Cytarabine in Patients with Secondary Acute Myeloid Leukemia (AML) The rate of complete remission with or without hematopoietic recovery (CR + CRi)

• Country None
• organs None
• Specialty None

ANTISOMA ACCEDE : Essai de phase 3 randomisé comparant l’efficacité et la tolérance de la cytarabine associée à de l’amonafide ou à de la daunorubicine, chez des patients ayant une leucémie aiguë myéloïde. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions] Phase III open-label randomized study of amonafide L-malate in combination with cytarabine compared to daunorubicin in combination with cytarabine in patients with secondary acute myeloid leukemia (AM...

• Country France
• organs Leucémies aiguës
• Specialty Chimiothérapie

AN OPEN LABEL, RANDOMISED, PHASE II STUDY OF AS1404 IN COMBINATION WITH CARBOPLATIN AND PACLITAXEL IN PATIENTS WITH PLATINUM-SENSITIVE RECURRENT OVARIAN EPITHELIAL CANCER The overall aim of this study is to determine whether AS1404 will increase efficacy of carboplatin and paclitaxel combination in treating patients with platinum-sensitive recurrent ovarian epithelial ...

• Country None
• organs None
• Specialty None

A Phase II, Randomised, Open-Label, Multicentre Study of AS1402 in Combination with Letrozole as First Line Treatment in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer The overall objectives of this study are to compare the efficacy, safety and tolerability of AS1402 in combination with letrozole to letrozole alone as first-line treatment in post menopausal women wi...

• Country None
• organs None
• Specialty None

An Open Label, Randomized, Phase I/II Study of DMXAA in Combination with Carboplatin and Paclitaxel in Patients with Locally Advanced and Metastatic Non-Small Cell Lung Cancer Determination of the safety, tolerability and efficacy of DMXAA in combination with carboplatin and paclitaxel in patients with locally advanced and metastatic (Stage IIIb and IV) NSCLC

• Country None
• organs None
• Specialty None